Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Unit Trust
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: South Korea

Dongbu Bio-Health Care Securities Investment Trust 1 - Equity

+ Add to Watchlist

6170153:KS

1,136.08 KRW 3.51 0.31%

As of 03:07:35 ET on 03/30/2015.

Snapshot for Dongbu Bio-Health Care Securities Investment Trust 1 - Equity (6170153)

Year To Date: +20.78% 3-Month: +20.78% 3-Year: +11.68% 52-Week Range: 912.07 - 1,165.09
1-Month: +3.26% 1-Year: +22.06% 5-Year: +9.96% Beta vs KOSPI: 0.57

Mutual Fund Chart for 6170153

No chart data available.
  • 6170153:KS 1,136.08
  • 1M
  • 1Y
Interactive 6170153 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for 6170153

Dongbu Bio-Health Care Securities Investment Trust 1 (Equity) is an open-end fund incorporated in South Korea. The Fund's objective is to achieve capital gains and current income. The Fund invests at least 50% of its total assets in Bio-Health Care stocks.

Inception Date: 11-03-2009 Telephone: 82-2-787-3700
Managers: YONG-NAM HAN
Web Site: www.dongbuam.co.kr

Fundamentals for 6170153

NAV (on 2015-03-30) 1,136.08
Assets (M) (on 2015-03-30) 78,061.39
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for 6170153

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2014-11-03) 93.34
Dividend Yield (ttm) 8.22

Fees & Expenses for 6170153

Front Load -
Back Load -
Current Mgmt Fee 0.72
Redemption Fee -
12b1 Fee -
Expense Ratio 1.76

Top Fund Holdings for 6170153

Filing Date: 10/31/2014
Name Position Value % of Total
HLB Inc 181,588 1,534,418,600 0.000%
Naturalendo Tech Co Ltd 20,146 1,130,190,600 0.000%
JVM Co Ltd 15,766 917,581,200 0.000%
InBody Co Ltd 28,979 865,023,150 0.000%
Chongkundang Holdings Corp 10,593 832,609,800 0.000%
Vieworks Co Ltd 22,674 820,798,800 0.000%
Chabiotech Co Ltd 54,540 801,738,000 0.000%
Chong Kun Dang Pharmaceutical 10,889 774,207,900 0.000%
Seegene Inc 9,408 553,190,400 0.000%
Daewoong Pharmaceutical Co Ltd 7,221 503,303,700 0.000%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil